General Information of Disease (ID: DISX0BGN)

Disease Name Combined oxidative phosphorylation defect type 9
Synonyms
combined oxidative phosphorylation deficiency 9; combined oxidative phosphorylation deficiency caused by mutation in MRPL3; COXPD9; MRPL3 combined oxidative phosphorylation deficiency; combined oxidative phosphorylation deficiency type 9
Definition
Combined oxidative phosphorylation defect type 9 is a rare mitochondrial disease due to a defect in mitochondrial protein synthesis characterized by initially normal growth and development followed by the infantile-onset of failure to thrive, psychomotor delay, poor feeding, dyspnea, severe hypertrophic cardiomyopathy and hepatomegaly. Laboratory studies report increased plasma lactate and alanine, abnormal liver enzymes and decreased activity of mitochondrial respiratory chain complexes I, III, IV, and V.
Disease Hierarchy
DISG5MW9: Combined oxidative phosphorylation deficiency
DISX0BGN: Combined oxidative phosphorylation defect type 9
Disease Identifiers
MONDO ID
MONDO_0013811
UMLS CUI
C4706315
OMIM ID
614582
MedGen ID
1634481
Orphanet ID
319509
SNOMED CT ID
763209008

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 1 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
MRPL3 OT4WV1WL Strong Autosomal recessive [1]
------------------------------------------------------------------------------------

References

1 Active-site mutants altering the cooperativity of E. coli phosphofructokinase. Nature. 1990 Feb 8;343(6258):575-6. doi: 10.1038/343575a0.